General Counsel · Arcus Biosciences, Inc. · Common Stock
Side
SELL
Value
$151K
Shares
6,810
Price
$22.16
Executed
Dec 17, 2025
Disclosed
Dec 18, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 17 executedDec 18, 2025 disclosed
RCUS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
1 prior trade recorded in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Tang Carolyn C. filed this Form 4 reporting a open-market sale of RCUS on Dec 17, 2025. It became public on Dec 18, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
General Counsel
Tang Carolyn C.cik:0001836662
Issuer
Arcus Biosciences, Inc.cik:0001724521
Revision history · 0
No field has changed since this record was first ingested.
